MSN Laboratories has signed a license agreement with the Defence Research and Development Organization (DRDO) for the manufacturing, distribution and marketing of Covid-19 drug 2-DG in India.
MSN said it will be launching the drug under the brand name MSN 2D in sachet form as a twice a day product in strength of 2.24 g.
Losing weight is a significant milestone, but for many, the bigger battle lies in keeping…
In recent months, a growing controversy has surfaced regarding the presence of heavy metals—specifically lead…
A new study published in Scientific Reports has shed light on the potential benefits of dietary…
Zinc is an essential mineral that plays a crucial role in maintaining overall health. Known…
A groundbreaking clinical trial, spearheaded by a team of Indian and international experts, has shed…
In an unprecedented discovery, scientists have uncovered a surprising connection between COVID-19 infections and the…